Oxycontin Maker Offers DOJ Settlement
Connecticut-based drugmaker Purdue Pharma says it’s working out a deal with the Justice Department amid investigations into its role in the U.S. opioid crisis.
The company, maker of the drug Oxycontin, faces more than $8 billion in penalties. Purdue says it’s offered a total settlement that would top $10 billion and include a hundred percent of its assets. The company says the settlement would pay for addiction treatment and medicine to reverse overdoses.
Purdue Pharma filed for bankruptcy protection last year amid thousands of civil cases from around the country. Critics say Purdue’s deceptive marketing of Oxycontin played a role in the opioid epidemic that’s killed hundreds of thousands of Americans.